U.S. Industrials Stock News

In February 2026, LegalZoom.com, Inc. announced the LegalZoom Connector, integrating its attorney-services platform directly into Anthropic’s Claude ecosystem to route AI-identified high-risk legal issues to its nationwide attorney network on a fixed-fee basis. This move deepens LegalZoom’s human-in-the-loop model by turning AI document review inside Claude into a feeder for higher-value expert legal services and subscriptions. We’ll now examine how this new Claude integration, alongside...

EPAM Systems (EPAM) is under pressure after its latest earnings release, as a sharp share price drop followed revenue and earnings beats. Investors focused instead on softer 2026 guidance and client specific headwinds. See our latest analysis for EPAM Systems. That sharp post earnings reaction sits within a much weaker run for EPAM, with a 7 day share price return of 20.58% decline, a 30 day share price return of 40.97% decline and a 1 year total shareholder return of 38.80% decline. This...

Bristol Myers Squibb (BMY) has just put fresh clinical data in front of investors, reporting positive phase 2 results for Reblozyl in alpha thalassemia and an FDA filing for iberdomide in multiple myeloma. See our latest analysis for Bristol-Myers Squibb. Those Reblozyl and iberdomide updates land against a backdrop of improving price momentum, with a 30 day share price return of 12.72% and a 90 day share price return of 25.08%, while the 1 year total shareholder return is 11.17%. This...

Charter Communications (CHTR) is back on investors' radar after a cluster of moves, including an industry first WiFi 7 launch, rural fiber expansion, and the appointment of turnaround veteran Nick Jeffery as Chief Operating Officer. See our latest analysis for Charter Communications. These product launches, rural fiber builds and leadership changes come as the share price sits at US$231.85, with a 30 day share price return of 20.95% and a 1 year total shareholder return of 35.37% decline...

Why ORIC Pharmaceuticals stock is back on investors’ radar ORIC Pharmaceuticals (ORIC) has drawn fresh attention after reporting Phase 1b data for its lead cancer drugs and securing new funding that management expects will cover operations into the second half of 2028. See our latest analysis for ORIC Pharmaceuticals. The recent Phase 1b readouts, extended cash runway into late 2028 and new equity programs have all landed alongside a strong 64.26% year to date share price return. The 3 year...

Earlier in February 2026, GE HealthCare received FDA 510(k) clearance for three MR innovations, the helium-free SIGNA Sprint with Freelium, the high-performance SIGNA Bolt 3T scanner, and the AI-driven SIGNA One workflow ecosystem, aimed at improving imaging efficiency, sustainability, and access across diverse care settings. This combination of helium independence, reduced power and space requirements, and end-to-end AI workflow support could meaningfully influence how hospitals think about...

Serve Robotics stock performance catches attention Serve Robotics (SERV) has drawn fresh investor attention after recent trading, with the stock last closing at US$9.67. Short term returns are mixed, with a 4.7% move over the past day and a 4.3% gain over the past week. Over the past month the share price shows a 24.1% decline, while the past 3 months reflect a 4.3% negative total return and the year to date move stands at an 18.3% decline. Over the past year, Serve Robotics has a 1.7%...

Key recent moves and what they mean for Figma stock Figma (FIG) has drawn fresh attention after a sharp 1 day move of about 10%, extending a roughly 19% gain over the past week while still reflecting weaker month and past 3 months returns. See our latest analysis for Figma. The recent 1 day share price return of 10.83% and 7 day share price return of 18.74% come after a weaker patch. The year to date share price return of negative 27.07% and 90 day share price return of negative 24.08%...

Olin Corporation recently closed a long-standing US$36.99 million shelf registration tied to an ESOP-related offering of 2,250,000 common shares and affirmed a quarterly dividend of US$0.20 per share payable on March 13, 2026 to shareholders of record on March 3, 2026. These actions come shortly after weaker fourth-quarter 2025 results and softer 2026 guidance, highlighting the tension between ongoing shareholder payouts and pressure on earnings and margins. We’ll now assess how Olin’s...

Ascendis Pharma A/S recently reported fourth-quarter 2025 results, with sales rising to €247.5 million from €173.92 million and the quarterly net loss narrowing to €33.56 million, while full-year 2025 sales increased to €720.13 million and the annual net loss narrowed to €228.03 million. Despite still operating at a loss, Ascendis cut its basic loss per share from €6.53 to €3.76 over 2025, highlighting how rapid revenue growth from its endocrinology portfolio is helping to improve earnings...

Royal Caribbean Group has appointed Christopher J. Wiernicki, former Chairman & CEO of American Bureau of Shipping, to its Board of Directors effective 17 February 2026, adding extensive expertise in marine design, safety management, digitalization, cyber security, and clean energy transition. His long track record in ship classification, advanced analytics and clean energy initiatives could influence how Royal Caribbean thinks about fleet efficiency, risk management and future...

In February 2026, RLJ Lodging Trust refinanced all of its debt maturities through 2028, extending its US$600 million revolver to 2031, upsizing and recasting a term loan to about US$570 million, adding a new US$150 million seven-year delayed-draw term loan maturing in 2033, and refinancing about US$155 million of mortgage loans to 2031. The company now has no debt maturing until 2029 and plans to use incremental proceeds to fully address its US$500 million senior notes due July 2026,...

What Triggered T1 Energy’s Latest Price Swing? T1 Energy (TE) rose 12.72% after a recent slide, as bargain hunters reacted to new clarity on Section 45X tax credit eligibility, executive changes in the finance team, and elevated short interest. See our latest analysis for T1 Energy. That sharp 12.72% 1 day share price return comes after a 16.59% 30 day share price decline. However, the 90 day share price return of 84.64% and very large 1 year total shareholder return suggest momentum has been...

Mitsui Sumitomo Insurance Co., LTD, a ten-percent owner of W. R. Berkley (NYSE:WRB), recently made substantial share purchases. The transactions were carried out in February 2026 through a pre arranged trading plan. The increased insider stake highlights fresh activity by a major shareholder that has not yet been widely discussed. W. R. Berkley operates as a commercial lines insurer, so this is a business tied closely to underwriting discipline, capital strength and risk management. Large...

If you are wondering whether Marzetti at around US$165.76 is a bargain, fully priced, or something in between, you are in the right place to assess what that share price could mean for you. Over the short term, the stock has moved around, with a 4.7% return over the last 7 days, a 1.7% decline over 30 days, a 0.7% return year to date, and a 13.7% decline over the past year, while the 5 year return sits at 4.7%. Recent attention on Marzetti has been shaped by ongoing coverage of the business...

Bath & Body Works (BBWI) has opened its first authorized U.S. storefront on Amazon, a shift in distribution aimed at reaching new customers, curbing gray market activity, and supporting its Consumer First Formula plan. See our latest analysis for Bath & Body Works. The Amazon launch follows several customer-focused moves, including expanded college campus distribution and recent promotions on candles. It also comes at a time when the 90 day share price return of 33.91% contrasts with a 1 year...

Recent performance snapshot Karman Holdings (KRMN) has been on the radar after a mix of strong longer term returns and a weaker month, with the stock up about 11% over the past week but down over the past month. See our latest analysis for Karman Holdings. At a share price of US$83.60, Karman’s recent 7 day share price return of 11.30% comes after a 30 day share price decline of 22.75%, while its 1 year total shareholder return of 178.67% points to strong longer term momentum that has...

If you are wondering whether Baker Hughes at around US$64.72 is starting to look expensive or if there is still value on the table, this article will walk you through what the numbers are really saying about the stock. The share price has recently been strong, with returns of 8.1% over the last 7 days, 20.0% over 30 days, 37.3% year to date and 49.9% over 1 year, while the 3 year return is 126.5% and the 5 year return is 200.4%. Recent news coverage has focused on Baker Hughes as a major...

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...

Getty Realty (GTY) is back in the spotlight after completing a follow on equity offering of 4,000,000 common shares at US$32.48 per share, raising about US$129.92 million in conjunction with related forward sale agreements. See our latest analysis for Getty Realty. The follow on offering comes after a run of solid reported results and a strong share price trend. Getty Realty’s 30 day share price return of 11.95% and year to date share price return of 18.32% sit alongside a 5 year total...

If you are wondering whether Tandem Diabetes Care at around US$26.90 is starting to look mispriced, you are not alone. The numbers give us plenty to unpack. The stock has seen sharp recent moves, with a 42.8% return over the last 7 days and 35.2% over the last 30 days. This is even though the 1 year return sits at a 19.3% decline and the 5 year return at a 71.2% decline. Recent news coverage has focused on Tandem Diabetes Care's position in diabetes technology and product updates that keep...

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...

In recent days, Rocket Companies has drawn increased attention as options markets price in very large potential stock moves ahead of its February 26, 2026 earnings release, amid elevated implied volatility and an extremely low put/call ratio that highlights heavily skewed positioning. This heightened speculation comes as Rocket advances its plan to become the largest U.S. mortgage servicer through the acquisition of Mr. Cooper Group, underlining how investors are weighing both...

Why Coherent’s recent performance is on investors’ radar Coherent (COHR) has moved sharply in recent months, with the share price up 29% over the past month and 65% in the past 3 months, drawing fresh attention from growth-focused investors. See our latest analysis for Coherent. That recent surge sits on top of a strong run, with Coherent’s 1-year total shareholder return very large and its 3-year total shareholder return close to 5x, suggesting momentum has been building rather than...